Your browser is no longer supported. Please, upgrade your browser.
Citius Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own8.50% Shs Outstand135.47M Perf Week-9.09%
Market Cap265.14M Forward P/E5.81 EPS next Y0.31 Insider Trans0.00% Shs Float123.17M Perf Month-16.67%
Income-21.10M PEG- EPS next Q-0.07 Inst Own12.80% Short Float13.74% Perf Quarter-21.74%
Sales- P/S- EPS this Y42.00% Inst Trans3.42% Short Ratio1.85 Perf Half Y25.00%
Book/sh1.30 P/B1.38 EPS next Y203.30% ROA-33.40% Target Price- Perf Year39.53%
Cash/sh0.70 P/C2.56 EPS next 5Y- ROE-39.60% 52W Range0.78 - 4.56 Perf YTD76.47%
Dividend- P/FCF- EPS past 5Y20.00% ROI- 52W High-60.53% Beta1.53
Dividend %- Quick Ratio35.20 Sales past 5Y- Gross Margin- 52W Low130.77% ATR0.18
Employees10 Current Ratio35.20 Sales Q/Q- Oper. Margin- RSI (14)34.30 Volatility3.45% 6.56%
OptionableYes Debt/Eq0.00 EPS Q/Q66.70% Profit Margin- Rel Volume0.49 Prev Close1.86
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume9.17M Price1.80
Recom2.00 SMA20-8.91% SMA50-29.07% SMA2002.75% Volume4,532,751 Change-3.23%
Aug-04-21 10:34AM  
Aug-03-21 04:29PM  
Jul-20-21 07:17AM  
Jul-07-21 07:15PM  
Jul-01-21 12:56PM  
Jun-23-21 07:51AM  
Jun-21-21 06:50PM  
Jun-17-21 06:00AM  
Jun-16-21 05:55PM  
Jun-15-21 09:20AM  
Jun-08-21 02:11PM  
Jun-07-21 09:00AM  
Jun-03-21 08:18AM  
May-25-21 02:52PM  
May-18-21 09:29AM  
May-17-21 12:30PM  
May-13-21 07:30AM  
May-11-21 04:30PM  
May-04-21 09:15AM  
Apr-29-21 09:37AM  
Apr-22-21 04:30PM  
Apr-19-21 08:53AM  
Mar-23-21 09:00AM  
Mar-04-21 10:11AM  
Feb-19-21 04:47PM  
Feb-17-21 12:28AM  
Feb-16-21 09:15AM  
Feb-08-21 08:35AM  
Feb-04-21 10:16AM  
Feb-02-21 08:00AM  
Jan-28-21 08:35AM  
Jan-27-21 01:00PM  
Jan-25-21 07:00AM  
Jan-06-21 09:00AM  
Dec-18-20 12:57AM  
Dec-15-20 09:40AM  
Dec-09-20 09:40AM  
Dec-08-20 09:15AM  
Dec-03-20 03:30PM  
Nov-30-20 09:15AM  
Nov-10-20 09:30AM  
Nov-09-20 09:30AM  
Oct-27-20 09:00AM  
Oct-13-20 07:30AM  
Oct-07-20 07:00AM  
Sep-30-20 09:45AM  
Sep-29-20 10:17AM  
Sep-22-20 08:15AM  
Sep-15-20 10:17AM  
Sep-08-20 10:00AM  
Sep-01-20 04:34PM  
Aug-27-20 09:00AM  
Aug-26-20 10:00AM  
Aug-13-20 09:45AM  
Aug-10-20 03:18PM  
Aug-05-20 05:32PM  
Aug-04-20 08:17AM  
Jul-22-20 10:30AM  
Jul-20-20 02:00PM  
Jul-14-20 08:47AM  
Jul-13-20 08:15AM  
Jun-30-20 08:54AM  
Jun-29-20 09:07AM  
Jun-26-20 09:00AM  
Jun-23-20 08:49AM  
Jun-22-20 01:17PM  
Jun-02-20 09:30AM  
May-26-20 08:15AM  
May-18-20 02:30PM  
May-15-20 06:49AM  
May-14-20 09:00AM  
May-13-20 08:15AM  
May-12-20 08:00AM  
Apr-27-20 09:30AM  
Apr-01-20 08:07AM  
Mar-26-20 09:06AM  
Mar-18-20 09:46AM  
Mar-16-20 06:22AM  
Mar-03-20 04:45PM  
Feb-26-20 08:00AM  
Feb-25-20 08:00AM  
Feb-10-20 08:28AM  
Feb-04-20 08:00AM  
Feb-03-20 08:00AM  
Jan-27-20 08:00AM  
Dec-19-19 08:00AM  
Dec-04-19 08:00AM  
Nov-08-19 08:00AM  
Oct-24-19 08:00AM  
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.